Question 1

Where can I buy Semaglutide?

Accepted Answer

Semaglutide (also known as Semaglutide Acetate) is available directly from New-U Research Compounds at https://new-u.io/peptide/semaglutide. Every batch is independently third-party tested by Janoshik Analytics and Freedom Diagnostics to >99% HPLC purity, supplied as lyophilised research-grade material, and shipped direct from source worldwide (approximately 6–14 business days).

Question 2

How much does Semaglutide cost?

Accepted Answer

Semaglutide starts at $45 for a 1-vial research pack (5mg per vial) at New-U Research Compounds, with 10 pack sizes available. Orders over $350 ship free.

Question 3

Is New-U Semaglutide third-party tested?

Accepted Answer

Yes. Every Semaglutide batch is verified by independent laboratories (Janoshik Analytics and Freedom Diagnostics) for identity and purity, with a batch-linked Certificate of Analysis confirming >99% purity by HPLC area normalisation.

Question 4

How fast does Semaglutide ship, and do you ship internationally?

Accepted Answer

Semaglutide ships direct from source, discreetly worldwide with cold-chain handling where required. Delivery is approximately 6–14 business days worldwide. Shipping is free on orders over $350. Card and cryptocurrency payments are accepted.

Question 5

Is it legal to buy Semaglutide?

Accepted Answer

GLP1-RC-SM is supplied strictly as laboratory research material and is not offered for human or veterinary use. Research use only - all claims made on this site are for testing and research use only. Regulatory requirements vary by product, intended use and jurisdiction. Purchasers are responsible for ensuring that acquisition and use of research material complies with applicable requirements.

Question 6

What is Semaglutide used for in research?

Accepted Answer

Semaglutide is a long-acting GLP-1 receptor agonist characterised in published research, with 94% homology to native human GLP-1 and a C18 fatty-diacid albumin-binding modification. GLP1-RC-SM is the New-U catalogue identifier for the analytically verified laboratory research material supplied here. New-U supplies Semaglutide as research-grade reference material for laboratory and in-vitro or animal-model investigation only. Mechanism, pharmacokinetics and study context are summarised on the Semaglutide research profile.

Question 7

What analytical documentation ships with GLP1-RC-SM?

Accepted Answer

Every GLP1-RC-SM order ships with the batch-linked Certificate of Analysis for the lot supplied: independent laboratory, report number, RP-HPLC purity result, mass-spectrometry identity confirmation and test date. Current batch certificates are published at https://new-u.io/coa/semaglutide before you order. Batch analysis reports identity and purity for the sample tested. It does not establish sterility, endotoxin or heavy-metal status, pharmaceutical equivalence, or any clinical property.

Question 8

Does published Semaglutide clinical research apply to GLP1-RC-SM?

Accepted Answer

No. Published clinical findings summarised on this page relate to the investigational materials and protocols used in those external studies. They do not establish the safety, efficacy, intended use or clinical equivalence of New-U GLP1-RC-SM research material. The two evidence types are kept separate on this page for that reason: batch analysis is New-U's own analytical work on the supplied lot, and the trial data is external work on the investigational or approved material those studies used.

Question 9

Can I buy Semaglutide online and how fast does it ship?

Accepted Answer

Yes. Semaglutide can be ordered online directly from New-U Research Compounds with card or cryptocurrency, shipped direct from source discreetly worldwide. Delivery is approximately 6–14 business days worldwide. Free shipping applies to orders over $350.

Question 10

Can I buy Semaglutide in bulk?

Accepted Answer

Semaglutide ships in 10-vial research packs as standard, in 10 pack sizes — the larger mg vials lower the per-mg cost. Multi-pack orders get direct-from-source pricing and free shipping over $350. For wholesale or recurring laboratory-supply volumes, contact New-U Research Compounds at https://new-u.io/contact.

Question 11

What should I look for when choosing where to buy Semaglutide?

Accepted Answer

For research-grade Semaglutide, verify four things: (1) independent third-party purity testing with a batch-linked Certificate of Analysis - New-U uses Janoshik Analytics and Freedom Diagnostics at >99% HPLC; (2) lyophilised material with documented storage and handling; (3) transparent direct-from-source pricing rather than marketplace markup; and (4) clear research-use-only framing. New-U Research Compounds meets all four at https://new-u.io/peptide/semaglutide.

Question 12

What is Semaglutide in scientific research?

Accepted Answer

Semaglutide is a 31-amino-acid GLP-1 receptor agonist characterised in published receptor-pharmacology and clinical research. It is approved as a medicine in some jurisdictions under other manufacturers' brand names; the material supplied here is not that finished pharmaceutical.

Question 13

What is GLP1-RC-SM?

Accepted Answer

GLP1-RC-SM is New-U's catalogue identifier for the laboratory research material offered through this research profile. It is not a medicine, a treatment, a generic pharmaceutical or a therapeutic product, it is not equivalent to any clinical or commercial product, and it is not offered for human or veterinary use.

Question 14

Which receptor systems are examined in Semaglutide research?

Accepted Answer

Published work characterises agonist activity at the GLP-1 receptor across four tissue contexts: pancreatic β-cells (glucose-dependent insulin secretion), pancreatic α-cells (glucagon suppression), the gastrointestinal tract (delayed gastric emptying) and hypothalamic circuits (POMC/CART activation, AgRP/NPY inhibition in preclinical models). Structural work additionally investigates the C18 fatty-diacid albumin-binding modification and the Aib8 substitution for altered proteolytic stability.

Question 15

What analytical testing accompanies GLP1-RC-SM?

Accepted Answer

Each released GLP1-RC-SM batch is tested by an independent analytical laboratory for purity by RP-HPLC area normalisation and for identity by mass spectrometry, and the result is published as a batch-linked Certificate of Analysis recording the laboratory, report number, measured purity and test date. Batch analysis reports identity and purity for the sample tested. It does not establish sterility, endotoxin or heavy-metal status, pharmaceutical equivalence, or any clinical property.

Question 16

Where can I view the current batch COA for GLP1-RC-SM?

Accepted Answer

The current batch certificate — laboratory, report number, measured purity and test date — is published at /coa/semaglutide, together with the testing history for the compound.

Question 17

What does >99% HPLC purity mean?

Accepted Answer

It is a purity figure obtained by reversed-phase high-performance liquid chromatography using area normalisation: the target peak accounts for more than 99% of the total integrated peak area in the chromatogram for the tested sample. It is a statement about chemical purity of that sample only, and says nothing about sterility, endotoxin content, pharmaceutical equivalence or any clinical property.

Question 18

What clinical trials are referenced on this page?

Accepted Answer

Five external studies of the reference medicine: STEP-1 (Wilding et al., NEJM 2021; PMID 33567185), SELECT (Lincoff et al., NEJM 2023; PMID 37952131), FLOW (Perkovic et al., NEJM 2024; DOI 10.1056/NEJMoa2403347), SOUL (McGuire et al., NEJM 2025; DOI 10.1056/NEJMoa2501006) and the structural paper by Lau et al. (J Med Chem 2015). Each reported result on this page is attributed to its study, arm and timepoint.

Question 19

How is published clinical research distinguished from New-U batch testing?

Accepted Answer

They are separate bodies of evidence. Published clinical research is external work on the approved finished pharmaceutical, conducted under those studies' own protocols; it establishes nothing about the material supplied here. New-U batch testing is analytical work on the GLP1-RC-SM lot itself — RP-HPLC purity and mass-spectrometry identity — and it establishes nothing clinical. A certificate of analysis combined with an external clinical paper does not amount to clinical validation of GLP1-RC-SM.

Question 20

Is GLP1-RC-SM the same as an approved branded medicine?

Accepted Answer

No. Approved branded semaglutide products are prescription, sterile finished pharmaceuticals manufactured under cGMP by their marketing authorisation holders. GLP1-RC-SM is unapproved laboratory research material supplied as a lyophilised powder. It is not equivalent to, a generic of, or a substitute for any approved product.

Question 21

How is Semaglutide different from native GLP-1?

Accepted Answer

Published structural work describes 94% sequence homology with native human GLP-1(7-37) plus three engineered modifications: an Aib substitution at position 8 investigated for DPP-IV resistance, an Arg substitution at position 34, and a C18 fatty diacid attached at Lys26. The fatty acid is reported to bind albumin, which the literature attributes the extension of apparent half-life from roughly 2 minutes to approximately 7 days to.

Question 22

What form is GLP1-RC-SM supplied in?

Accepted Answer

GLP1-RC-SM is supplied as a lyophilised powder in sealed vials, in sealed 10-vial research packs across the listed strengths, with a batch-linked Certificate of Analysis.

Question 23

How should laboratory research material be stored?

Accepted Answer

Store the lyophilised powder in a freezer at −20 °C. If a laboratory protocol requires the material in solution, hold the resulting solution refrigerated at 1–6 °C, protected from light, and avoid repeated warming and cooling cycles, which can degrade the fatty-acid modification. Storage conditions are laboratory handling information only.

Question 24

Is Semaglutide research compared head-to-head with Tirzepatide research?

Accepted Answer

One published trial, SURMOUNT-5 (NEJM 2025), was designed as a head-to-head comparison and reported a larger mean change from baseline in body weight in the tirzepatide arm than the semaglutide arm at week 72 (−20.2% vs −13.7%). Results from separate trials of the two compounds are not head-to-head comparisons and the study designs do not support treating them as such.

Semaglutide Research

Inside New-U Research Compounds

GLP1-RC-SM Research Material

Why buy Semaglutide from New-U Research Compounds

What is Semaglutide?

Semaglutide at a glance

Semaglutide pricing

Frequently asked questions